We bring molecular imaging into the hands of cancer surgeons.

Surgical oncology stands as one of the most important means in the fight against cancer. Every day, thousands of cancer-related surgeries are performed across the globe, saving lives and bringing hope to millions. And yet, improvements in the workflow and technology of cancer surgeries have been slow. Now, with Ziteo Medical, it is making a massive leap forward.

At Ziteo Medical, we find ourselves at the nexus of surgical oncology, molecular imaging, computer vision, and augmented reality to take surgical removal of cancerous tissue to the next level. We are building the 21st century tool that cancer surgeons need: a handheld, miniaturized, intraoperative, molecular imaging device.


Ziteo Medical selected to be part of the RESI Innovation Challenge
San Diego, CA, May 2017: The RESI conference hand picked the most innovative technologies in Life Science for its RESI Innovation Challenge. Ziteo Medical will be presenting its groundbreaking imaging technology at the RESI conference on June 19, 2017 in San Diego, CA.


Ziteo Medical collaborates with the Stanford School of Medicine
Berkeley, CA, September 2016: NIH SBIR phase I granted to Ziteo Medical in collaboration with the Stanford School of Medicine.

Ziteo Medical named fellow of the CLSI's FAST (Fellows All-Star Team) Accelerator

South San Francisco, CA, December 2015: Ziteo Medical has graduated from the intense California Life Science Institute’s (CLSI) FAST Advisory Program. Twice a year, the CLSI identifies select startups and provides them with coaching in business model, product development, and commercialization strategy.